Natural remedies and hormone preparations - Potential risk for breast cancer patients. Mapping of the use of complementary alternative medicine which possibly counteract the treatment;Naturläkemedel och hormonpreparat - Potentiell risk för bröstcancerpatienter. Studie kartlägger bruk av medel som kanske motverkar behandlingen

Lakartidningen

Volumn 102, Issue 44, 2005, Pages 3226-3231

  Malekzadeh, Farnaz ^a   Rose, Carsten ^b   Ingvar, Christian ^b   Jernström, Helena ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Avdelningen För Onkologi ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AROMATASE INHIBITOR; ORAL CONTRACEPTIVE AGENT; PLANT MEDICINAL PRODUCT; TAMOXIFEN;

ARTICLE; BREAST TUMOR; FEMALE; HERB DRUG INTERACTION; HORMONE SUBSTITUTION; HUMAN; PHYTOTHERAPY; QUESTIONNAIRE; RISK FACTOR;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HERB-DRUG INTERACTIONS; HORMONE REPLACEMENT THERAPY; HUMANS; PHYTOTHERAPY; PLANT PREPARATIONS; QUESTIONNAIRES; RISK FACTORS; TAMOXIFEN;

EID: 27744579747     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Socialstyrelsens cancerregister 2003. http://www.sos.se/epc/cancer
2. Alvan G. Naturläkemedel i framtidens läkemedelsanvändning. http://www.mpa.se/naturlakemedel/seminarium/041110_alvan.pdf 2004
3. Nilsson M, Trehn G, Asplund K. Use of complementary and alternative medicine remedies in Sweden. A population-based longitudinal study within the northern Sweden MONICA Project. Multinational monitoring of trends and determinants of cardiovascular disease. J Intern Med 2001;250(3):225-33.
4. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004; 22(12):2489-503.
5. Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomarkers Prev 2004;13(5):698-708.
6. Mansky PJ, Straus SE. St. John's wort: more implications for cancer patients. J Natl Cancer Inst 2002;94(16):1187-8.
7. Peebles KA, Baker RK, Kurz EU, Schneider BJ, Kroll DJ. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum). Biochem Pharmacol 2001;62(8):1059-70.
8. Damkier A. Kraeftpatienters brug af alternativ behandling [dissertation]. Odense: Syddansk Universitet; 2000.
9. Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer 2004;101(7):1490-500.
10. Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, et al. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years. Cancer Epidemiol Biomarkers Prev 2003;12(11 Pt 1):1175-81.
11. Allred CD, Allred KF, Ju YH, Clausen LM, Doerge DR, Schantz SL, et al. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis 2004;25(2):211-8.
12. Allred CD, Allred KF, Ju YH, GoeppingerTS, Doerge DR, Helferich WG. Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 2004;25(9):1649-57.
13. Maguire P, Faulkner A. Communicate with cancer patients: 2. Handling uncertainty, collusion, and denial. BMJ 1988;297(6654):972-4.
14. Maguire P, Faulkner A. Communicate with cancer patients: 1. Handling bad news and difficult questions. BMJ 1988;297(6653):907-9.
15. Vårdprogram för bröstcancer. Lund: Sydsvenska bröstcancergruppen; 1997 (reviderat 2003). http://www.ocsyd.lu.se/Vardprog/ brost/kap1-8.html
16. von Schoultz E, Rutqvist LE. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial. J Natl Cancer Inst 2005;97(7):533-5.